Teva Pharma Industries Ltd
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||
| 41.9 | 28.5 | 36.1 | 37.4 | 64.3 | 30.2 | 26.4 | 24.2 | 62.0 | 27.3 | 45.9 | 19.8 | 55.0 | 25.2 | 14.4 | 13.1 | 16.6 | 26.9 | 16.1 | 35.7 | 106.0 | – | – | – | – | 21.2 | – | – | – | 26.0 | |
| 3.2 | 2.6 | 2.2 | 3.4 | 5.5 | 4.0 | 4.3 | 5.1 | 4.3 | 5.6 | 3.0 | 4.1 | 3.2 | 3.6 | 3.0 | 2.0 | 1.6 | 1.7 | 2.4 | 2.9 | 1.6 | 0.9 | 0.8 | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 | 1.5 | 2.1 | |
| 5.8 | 4.7 | 3.8 | 5.9 | 8.3 | 6.1 | 5.9 | 5.1 | 3.8 | 4.8 | 2.2 | 2.8 | 2.1 | 2.6 | 2.2 | 1.6 | 1.4 | 1.5 | 2.1 | 1.9 | 1.0 | 1.1 | 1.1 | 0.8 | 1.1 | 0.9 | 1.3 | 1.6 | 4.6 | 4.6 | |
| 3.5 | 2.8 | 2.5 | 3.6 | 5.9 | 4.4 | 4.7 | 5.2 | 4.6 | 5.7 | 3.5 | 4.5 | 3.7 | 3.9 | 3.2 | 2.7 | 2.2 | 2.2 | 2.8 | 3.0 | 3.2 | 2.3 | 2.3 | 2.1 | 2.1 | 1.9 | 1.9 | 1.8 | 2.4 | 2.9 | |
| 19.4 | 13.6 | 10.5 | 13.7 | 21.9 | 18.7 | 22.8 | 16.9 | 15.8 | 19.4 | 11.5 | 17.7 | 25.3 | 22.4 | 10.8 | 11.6 | 11.4 | 14.1 | 9.6 | 9.4 | 24.3 | – | 230.4 | 8.0 | 7.5 | 6.7 | – | 65.2 | 8.9 | 15.9 | |
| – | 22.2 | – | 50.9 | 125.2 | 60.4 | 56.1 | 39.9 | 21.9 | 27.6 | 15.0 | 30.4 | 13.7 | 19.0 | 14.0 | 11.7 | 9.4 | 15.5 | 11.8 | 11.9 | 8.1 | 7.3 | 8.8 | 25.5 | 16.6 | 37.5 | 9.7 | 13.8 | 33.2 | 31.9 | |
| -4.6% | 4.5% | -2.6% | 2.0% | 0.8% | 1.7% | 1.8% | 2.5% | 4.6% | 3.6% | 6.7% | 3.3% | 7.3% | 5.3% | 7.1% | 8.5% | 10.7% | 6.5% | 8.5% | 8.4% | 12.4% | 13.6% | 11.4% | 3.9% | 6.0% | 2.7% | 10.3% | 7.2% | 3.0% | 3.1% | |
| Margins | ||||||||||||||||||||||||||||||
| 42.3% | 43.7% | 43.0% | 45.5% | 45.0% | 40.8% | 43.5% | 46.4% | 46.7% | 47.2% | 50.7% | 51.8% | 53.8% | 53.0% | 56.2% | 52.0% | 52.4% | 52.7% | 54.5% | 57.8% | 54.1% | 48.4% | 44.0% | 44.6% | 46.4% | 47.8% | 46.7% | 48.2% | 48.7% | 51.8% | |
| 13.6% | 15.6% | 13.0% | 15.5% | 14.0% | 17.4% | 20.8% | 26.8% | 12.0% | 25.0% | 9.5% | 25.5% | 10.3% | 17.3% | 24.0% | 17.0% | 10.9% | 8.1% | 19.5% | 17.1% | 9.8% | -78.1% | -8.7% | -2.6% | -21.4% | 10.8% | -14.7% | 2.7% | -1.8% | 12.5% | |
| 7.7% | 9.1% | 6.2% | 9.2% | 8.5% | 13.4% | 16.3% | 21.1% | 6.9% | 20.4% | 6.5% | 20.7% | 5.7% | 14.4% | 20.7% | 15.1% | 9.7% | 6.2% | 15.1% | 8.1% | 1.5% | -72.7% | -11.4% | -5.9% | -24.0% | 2.6% | -16.4% | -3.5% | -9.9% | 8.2% | |
| -14.9% | 11.7% | -5.9% | 6.7% | 4.4% | 6.7% | 7.7% | 12.8% | 19.5% | 20.2% | 19.8% | 13.5% | 23.0% | 19.1% | 21.3% | 16.8% | 17.1% | 10.9% | 20.7% | 24.3% | 19.7% | 11.8% | 9.5% | 2.5% | 3.8% | 1.5% | 7.0% | 5.3% | 4.5% | 6.7% | |
| Returns | ||||||||||||||||||||||||||||||
| 13.7% | 16.6% | 10.4% | 15.9% | 12.9% | 20.2% | 22.4% | 21.0% | 6.2% | 17.7% | 4.9% | 14.2% | 3.9% | 10.4% | 15.2% | 12.4% | 8.6% | 5.6% | 13.1% | 5.3% | 1.0% | -93.7% | -14.6% | -7.2% | -39.8% | 4.1% | -31.3% | -7.4% | -30.5% | 17.8% | |
| 5.9% | 8.5% | 4.8% | 6.9% | 5.2% | 8.0% | 8.9% | 11.7% | 3.4% | 10.3% | 2.7% | 8.3% | 1.9% | 5.9% | 8.5% | 5.5% | 3.9% | 2.7% | 6.6% | 2.9% | 0.4% | -23.0% | -3.5% | -1.7% | -7.9% | 0.9% | -5.6% | -1.3% | -4.2% | 3.5% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||
| 280 | 189 | 277 | 199 | 735 | 684 | 1,090 | 402 | 1,504 | 873 | 3,995 | 3,700 | 6,589 | 3,617 | 4,294 | 13,420 | 11,839 | 11,153 | 8,101 | 2,986 | 34,812 | 31,512 | 27,134 | 24,932 | 23,742 | 20,878 | 18,411 | 16,607 | 14,483 | 13,250 | |
| 1.6 | 0.8 | 1.1 | 0.6 | 1.6 | 1.4 | 2.1 | 0.4 | 1.1 | 0.6 | 1.6 | 1.5 | 4.0 | 1.5 | 0.9 | 3.2 | 3.0 | 3.5 | 1.4 | 0.5 | 12.1 | – | 145.9 | 5.6 | 5.1 | 4.7 | – | 38.4 | 3.3 | 4.2 | |
| 43.0% | 51.5% | 45.9% | 43.3% | 40.3% | 39.9% | 39.5% | 55.6% | 55.9% | 58.2% | 54.4% | 58.6% | 49.5% | 56.9% | 56.2% | 44.3% | 45.0% | 47.5% | 50.2% | 54.9% | 35.9% | 24.6% | 24.2% | 24.3% | 19.8% | 21.6% | 17.7% | 17.3% | 13.7% | 19.4% | |
| 0.6 | 0.4 | 0.5 | 0.4 | 1.0 | 1.1 | 1.0 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.5 | 0.3 | 0.3 | 0.7 | 0.6 | 0.5 | 0.4 | 0.3 | 1.1 | 1.9 | 2.0 | 1.9 | 2.6 | 2.2 | 2.7 | 2.6 | 3.3 | 2.1 | |
| Per Share | ||||||||||||||||||||||||||||||
| 0.15 | 0.21 | 0.14 | 0.24 | 0.28 | 0.51 | 0.73 | 1.17 | 0.48 | 1.57 | 0.68 | 2.35 | 0.77 | 2.23 | 3.62 | 3.09 | 2.25 | 1.49 | 3.56 | 1.84 | 0.34 | -16.01 | -2.11 | -0.92 | -3.64 | 0.38 | -2.20 | -0.50 | -1.45 | 1.20 | |
| 1.95 | 2.28 | 2.29 | 2.61 | 3.36 | 3.81 | 4.48 | 5.55 | 6.98 | 7.71 | 10.44 | 11.33 | 13.52 | 15.51 | 17.50 | 20.51 | 23.27 | 23.90 | 23.63 | 22.75 | 22.79 | 22.03 | 18.47 | 15.48 | 15.21 | 14.34 | 13.45 | 14.16 | 14.63 | 14.71 | |
| 1.09 | 1.25 | 1.35 | 1.51 | 2.21 | 2.53 | 3.26 | 5.58 | 7.83 | 8.87 | 13.84 | 16.53 | 19.88 | 21.45 | 23.83 | 24.85 | 26.08 | 26.55 | 27.17 | 34.45 | 34.69 | 17.09 | 14.40 | 12.81 | 9.16 | 9.28 | 7.03 | 6.71 | 4.75 | 6.74 | |
| -0.29 | 0.27 | -0.13 | 0.18 | 0.15 | 0.25 | 0.34 | 0.71 | 1.36 | 1.56 | 2.07 | 1.53 | 3.11 | 2.96 | 3.72 | 3.45 | 3.97 | 2.60 | 4.89 | 5.52 | 4.50 | 2.59 | 1.76 | 0.38 | 0.58 | 0.21 | 0.94 | 0.75 | 0.66 | 0.98 | |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.